Our Amicus Briefs | Biosimilars & Generics | AAM
AAM All Access Podcast - AAM CEO Dan Leonard convenes industry and policy experts to explore why the Inflation Reduction Act (f/k/a Build Back Better) reduces generic and biosimilar competition.

Amicus Briefs

The Association for Accessible Medicines and its Biosimilars Council advocates in state and federal courts to support patient access to affordable generic and biosimilar medicines. We file amicus briefs in litigation that affects the ability of our members to deliver such medicines to patients in need. Below you will find recent amicus briefs that AAM has filed on behalf of our member companies.

Association for Accessible Medicines


Sign-up for Updates

Receive relevant industry news, event information and the latest resources on biosimilars and generic medicines.

Stay Connected

For the latest updates, follow us on social media.